1
|
Chen Q, Nie X, Huang W, Wang C, Lai R, Lu Q, He Q, Yu X. Unlocking the potential of chicken liver byproducts: Identification of antioxidant peptides through in silico approaches and anti-aging effects of a selected peptide in Caenorhabditis elegans. Int J Biol Macromol 2024; 272:132833. [PMID: 38834112 DOI: 10.1016/j.ijbiomac.2024.132833] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/14/2023] [Revised: 01/28/2024] [Accepted: 05/30/2024] [Indexed: 06/06/2024]
Abstract
Chicken meat processing generates a substantial number of byproducts, which are either underutilized or improperly disposed. In this study, we employed in silico approaches to identify antioxidant peptides in chicken liver byproducts. Notably, the peptide WYR exhibited remarkable 2,2-azino-bis-(3-ethylbenzothiazoline-6-sulfonic acid) diammonium salt (ABTS) radical scavenging activity with an IC50 of 0.13 ± 0.01 mg/mL and demonstrated stability under various conditions, including thermal, pH, NaCl, and simulated gastrointestinal digestion. Molecular docking analysis revealed significant hydrogen bonding interactions, while molecular dynamics showed differential stability with ABTS and 2,2-Diphenyl-1-picrylhydrazyl (DPPH). WYR exhibited improved stress resistance, decreased levels of reactive oxygen species (ROS), elevated the activities of superoxide dismutase (SOD) and catalase (CAT), and modulated the expression of crucial genes through the insulin/insulin-like growth factor (IIS) signaling pathway, mitogen-activated protein kinase (MAPK), and heat shock transcription factor-1 (HSF-1) pathways. These effects collectively contributed to the extension of Caenorhabditis elegans' lifespan. This study not only provides an effective method for antioxidant peptide analysis but also highlights the potential for enhancing the utilization of poultry byproducts.
Collapse
Affiliation(s)
- Qianzi Chen
- Engineering Research Center of Active Substance and Biotechnology, Ministry of Education, College of Life Science, Chongqing Normal University, Chongqing 401331, China
| | - Xuekui Nie
- Engineering Research Center of Active Substance and Biotechnology, Ministry of Education, College of Life Science, Chongqing Normal University, Chongqing 401331, China
| | - Wangxiang Huang
- Engineering Research Center of Active Substance and Biotechnology, Ministry of Education, College of Life Science, Chongqing Normal University, Chongqing 401331, China
| | - Chen Wang
- Engineering Research Center of Active Substance and Biotechnology, Ministry of Education, College of Life Science, Chongqing Normal University, Chongqing 401331, China
| | - Ren Lai
- Key Laboratory of Animal Models and Human Disease Mechanisms of Chinese Academy of Sciences/Key Laboratory of Bioactive Peptides of Yunnan Province, Kunming Institute of Zoology, China
| | - Qiumin Lu
- Key Laboratory of Animal Models and Human Disease Mechanisms of Chinese Academy of Sciences/Key Laboratory of Bioactive Peptides of Yunnan Province, Kunming Institute of Zoology, China
| | - Qiyi He
- Engineering Research Center of Active Substance and Biotechnology, Ministry of Education, College of Life Science, Chongqing Normal University, Chongqing 401331, China.
| | - Xiaodong Yu
- Engineering Research Center of Active Substance and Biotechnology, Ministry of Education, College of Life Science, Chongqing Normal University, Chongqing 401331, China.
| |
Collapse
|
2
|
Abstract
Plant disease control requires novel approaches to mitigate the spread of and losses caused by current, emerging, and re-emerging diseases and to adapt plant protection to global climate change and the restrictions on the use of conventional pesticides. Currently, disease management relies mainly on biopesticides, which are required for the sustainable use of plant-protection products. Functional peptides are candidate biopesticides because they originate from living organisms or are synthetic analogs and provide novel mechanisms of action against plant pathogens. Hundreds of compounds exist that cover an extensive range of activities against viruses, bacteria and phytoplasmas, fungi and oomycetes, and nematodes. Natural sources, chemical synthesis, and biotechnological platforms may provide peptides at large scale for the industry and growers. The main challenges for their use in plant disease protection are (a) the requirement of stability in the plant environment and counteracting resistance in pathogen populations, (b) the need to develop suitable formulations to increase their shelf life and methods of application, (c) the selection of compounds with acceptable toxicological profiles, and (d) the high cost of production for agricultural purposes. In the near future, it is expected that several functional peptides will be commercially available for plant disease control, but more effort is needed to validate their efficacy at the field level and fulfill the requirements of the regulatory framework.
Collapse
Affiliation(s)
- Emilio Montesinos
- Institute of Food and Agricultural Technology, Plant Pathology-CIDSAV, University of Girona, Girona, Spain;
| |
Collapse
|
3
|
Efficacy of natural antimicrobial peptides versus peptidomimetic analogues: a systematic review. Future Med Chem 2022; 14:1899-1921. [PMID: 36421051 DOI: 10.4155/fmc-2022-0160] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022] Open
Abstract
Aims: This systematic review was carried out to determine whether synthetic peptidomimetics exhibit significant advantages over antimicrobial peptides in terms of in vitro potency. Structural features - molecular weight, charge and length - were examined for correlations with activity. Methods: Original research articles reporting minimum inhibitory concentration values against Escherichia coli, indexed until 31 December 2020, were searched in PubMed/ScienceDirect/Google Scholar and evaluated using mixed-effects models. Results: In vitro antimicrobial activity of peptidomimetics resembled that of antimicrobial peptides. Net charge significantly affected minimum inhibitory concentration values (p < 0.001) with a trend of 4.6% decrease for increments in charge by +1. Conclusion: AMPs and antibacterial peptidomimetics exhibit similar potencies, providing an opportunity to exploit the advantageous stability and bioavailability typically associated with peptidomimetics.
Collapse
|
4
|
Vasilchenko AS, Rogozhin EA. Sub-inhibitory Effects of Antimicrobial Peptides. Front Microbiol 2019; 10:1160. [PMID: 31178852 PMCID: PMC6543913 DOI: 10.3389/fmicb.2019.01160] [Citation(s) in RCA: 38] [Impact Index Per Article: 7.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/06/2018] [Accepted: 05/07/2019] [Indexed: 01/01/2023] Open
Abstract
Antimicrobials, and particularly antimicrobial peptides (AMPs), have been thoroughly studied due to their therapeutic potential. The research on their exact mode of action on bacterial cells, especially at under sublethal concentrations, has resulted in a better understanding of the unpredictable nature of bacterial behavior under stress conditions. In this review, we were aiming to gather the wide yet still under-investigated knowledge about various AMPs and their subinhibition effects on cellular and molecular levels. We describe how AMP action is non-linear and unpredictable, also showing that exposure to AMP can lead to antimicrobial resistance via triggering various regulatory systems. Being one of the most known types of antimicrobials, bacteriocins have dual action and can also be utilized by microorganisms as signaling molecules at naturally achievable sub-inhibitory concentrations. The unpredictable nature of AMP action and the pathogenic response triggered by them remains an area of knowledge that requires further investigation.
Collapse
Affiliation(s)
- Alexey S. Vasilchenko
- Institute of Environmental and Agricultural Biology (X-BIO), Tyumen State University, Tyumen, Russia
| | - Eugene A. Rogozhin
- Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow, Russia
- Gause Institute of New Antibiotics, Moscow, Russia
| |
Collapse
|
5
|
Rogozhin EA, Sadykova VS, Baranova AA, Vasilchenko AS, Lushpa VA, Mineev KS, Georgieva ML, Kul'ko AB, Krasheninnikov ME, Lyundup AV, Vasilchenko AV, Andreev YA. A Novel Lipopeptaibol Emericellipsin A with Antimicrobial and Antitumor Activity Produced by the Extremophilic Fungus Emericellopsis alkalina. Molecules 2018; 23:molecules23112785. [PMID: 30373232 PMCID: PMC6278523 DOI: 10.3390/molecules23112785] [Citation(s) in RCA: 30] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/02/2018] [Revised: 10/23/2018] [Accepted: 10/25/2018] [Indexed: 01/21/2023] Open
Abstract
Soil fungi are known to contain a rich variety of defense metabolites that allow them to compete with other organisms (fungi, bacteria, nematodes, and insects) and help them occupy more preferential areas at the expense of effective antagonism. These compounds possess antibiotic activity towards a wide range of other microbes, particularly fungi that belong to different taxonomical units. These compounds include peptaibols, which are non-ribosomal synthesized polypeptides containing non-standard amino acid residues (alpha-aminoisobutyric acid mandatory) and some posttranslational modifications. We isolated a novel antibiotic peptide from the culture medium of Emericellopsis alkalina, an alkalophilic strain. This peptide, called emericellipsin A, exhibited a strong antifungal effect against the yeast Candida albicans, the mold fungus Aspergillus niger, and human pathogen clinical isolates. It also exhibited antimicrobial activity against some Gram-positive and Gram-negative bacteria. Additionally, emericellipsin A showed a significant cytotoxic effect and was highly active against Hep G2 and HeLa tumor cell lines. We used NMR spectroscopy to reveal that this peptaibol is nine amino acid residues long and contains non-standard amino acids. The mode of molecular action of emericellipsin A is most likely associated with its effects on the membranes of cells. Emericellipsin A is rather short peptaibol and could be useful for the development of antifungal, antibacterial, or anti-tumor remedies.
Collapse
Affiliation(s)
- Eugene A Rogozhin
- Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry, RAS, ul. Miklukho-Maklaya, 16/10, Moscow 117997, Russia.
- Gause Institute of New Antibiotics, ul. Bolshaya Pirogovskaya, 11, Moscow 119021, Russia.
| | - Vera S Sadykova
- Gause Institute of New Antibiotics, ul. Bolshaya Pirogovskaya, 11, Moscow 119021, Russia.
| | - Anna A Baranova
- Gause Institute of New Antibiotics, ul. Bolshaya Pirogovskaya, 11, Moscow 119021, Russia.
| | | | - Vladislav A Lushpa
- Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry, RAS, ul. Miklukho-Maklaya, 16/10, Moscow 117997, Russia.
- Moscow Institute of Physics and Technology, Institutskiy per., 9, Dolgoprudnyi 141701, Russia.
| | - Konstantin S Mineev
- Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry, RAS, ul. Miklukho-Maklaya, 16/10, Moscow 117997, Russia.
- Moscow Institute of Physics and Technology, Institutskiy per., 9, Dolgoprudnyi 141701, Russia.
| | - Marina L Georgieva
- Gause Institute of New Antibiotics, ul. Bolshaya Pirogovskaya, 11, Moscow 119021, Russia.
- Lomonosov Moscow State University, 1-12 Leninskie Gory, Moscow 119991, Russia.
| | - Alexander B Kul'ko
- Moscow Government Health Department Scientific and Clinical Antituberculosis Center, ul. Stromynka, 10, Moscow 107014, Russia.
| | - Mikhail E Krasheninnikov
- Institute of Molecular Medicine, Advanced Cell Technologies Department, Institute for Regenerative Medicine, Sechenov First Moscow State Medical University, Trubetskaya St. 8, Bldg. 2, Moscow 119991, Russia.
| | - Alexey V Lyundup
- Institute of Molecular Medicine, Advanced Cell Technologies Department, Institute for Regenerative Medicine, Sechenov First Moscow State Medical University, Trubetskaya St. 8, Bldg. 2, Moscow 119991, Russia.
| | | | - Yaroslav A Andreev
- Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry, RAS, ul. Miklukho-Maklaya, 16/10, Moscow 117997, Russia.
- Institute of Molecular Medicine, Advanced Cell Technologies Department, Institute for Regenerative Medicine, Sechenov First Moscow State Medical University, Trubetskaya St. 8, Bldg. 2, Moscow 119991, Russia.
| |
Collapse
|
6
|
Vasilchenko AS, Vasilchenko AV, Pashkova TM, Smirnova MP, Kolodkin NI, Manukhov IV, Zavilgelsky GB, Sizova EA, Kartashova OL, Simbirtsev AS, Rogozhin EA, Duskaev GK, Sycheva MV. Antimicrobial activity of the indolicidin-derived novel synthetic peptide In-58. J Pept Sci 2018; 23:855-863. [PMID: 29193518 DOI: 10.1002/psc.3049] [Citation(s) in RCA: 15] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/20/2017] [Revised: 09/28/2017] [Accepted: 10/01/2017] [Indexed: 12/26/2022]
Abstract
Natural peptides with antimicrobial activity are extremely diverse, and peptide synthesis technologies make it possible to significantly improve their properties for specific tasks. Here, we investigate the biological properties of the natural peptide indolicidin and the indolicidin-derived novel synthetic peptide In-58. In-58 was generated by replacing all tryptophan residues on phenylalanine in D-configuration; the α-amino group in the main chain also was modified by unsaturated fatty acid. Compared with indolicidin, In-58 is more bactericidal, more resistant to proteinase K, and less toxic to mammalian cells. Using molecular physics approaches, we characterized the action of In-58 on bacterial cells at the cellular level. Also, we have found that studied peptides damage bacterial membranes. Using the Escherichia coli luminescent biosensor strain MG1655 (pcolD'::lux), we investigated the action of indolicidin and In-58 at the subcellular level. At subinhibitory concentrations, indolicidin and In-58 induced an SOS response. Our data suggest that indolicidin damages the DNA, but bacterial membrane perturbation is its principal mode of action. Copyright © 2017 European Peptide Society and John Wiley & Sons, Ltd.
Collapse
Affiliation(s)
- A S Vasilchenko
- Tyumen State University, ul. Volodarsky, 6, Tyumen, 625003, Russia
| | - A V Vasilchenko
- Tyumen State University, ul. Volodarsky, 6, Tyumen, 625003, Russia
| | - T M Pashkova
- Institute of Cellular and Intracellular Symbiosis, Russian Academy of Sciences, ul. Pionerskaya, Orenburg, 11, Russia
| | - M P Smirnova
- Research Institute of Highly Pure Biopreparations, Pudozhsakya str., St. Petersburg, 197110, Russia
| | - N I Kolodkin
- Research Institute of Highly Pure Biopreparations, Pudozhsakya str., St. Petersburg, 197110, Russia
| | - I V Manukhov
- State Research Institute of Genetics and Selection of Industrial Microorganisms, 1, 1st Dorozhny pr., Moscow, 113545, Russia.,Moscow Institute of Physics and Technology (State University), 9 Institutskiy per., Dolgoprudnyi, 141701, Russia
| | - G B Zavilgelsky
- State Research Institute of Genetics and Selection of Industrial Microorganisms, 1, 1st Dorozhny pr., Moscow, 113545, Russia
| | - E A Sizova
- All-Russia Research Institute of Beef Cattle Breeding, Russian Academy of Sciences, ul. Pionerskaya, Orenburg, 11, Russia.,Orenburg State University, Pobedy str., Orenburg, 13, Russia
| | - O L Kartashova
- Institute of Cellular and Intracellular Symbiosis, Russian Academy of Sciences, ul. Pionerskaya, Orenburg, 11, Russia
| | - A S Simbirtsev
- Research Institute of Highly Pure Biopreparations, Pudozhsakya str., St. Petersburg, 197110, Russia
| | - E A Rogozhin
- Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Science, ul. Miklukho-Maklaya, 16, Orenburg, /10, Russia.,Gause Institute of New Antibiotics, ul. Bolshaya Pirogovskaya, Moscow, 11, Russia
| | - G K Duskaev
- All-Russia Research Institute of Beef Cattle Breeding, Russian Academy of Sciences, ul. Pionerskaya, Orenburg, 11, Russia
| | - M V Sycheva
- Institute of Cellular and Intracellular Symbiosis, Russian Academy of Sciences, ul. Pionerskaya, Orenburg, 11, Russia.,Orenburg State Agrarian University, ul. Chelyuskintsev, Orenburg, 18, Russia
| |
Collapse
|
7
|
Abstract
Discovering new therapeutics for human viral diseases is important for combatting emerging infectious viruses and omnipresent circulating viruses as well as those that can become resistant to the drugs we currently have available. The innate host defense peptide (HDP) repertoire present in animals is a wealth of potential antimicrobial agents that could be mined to meet these needs. While much of the body of research regarding HDPs is in the context of bacteria, there is increasing evidence that they can be an effective source for antivirals. Peptides can be identified in a number of ways, including eco-conservation-minded approaches. Those shown to have antiviral properties can be modified to exhibit desired properties as the relationship between structure and function is elucidated and then developed into therapeutics for human use. This review looks at the discovery and therapeutic potential of HDPs for human viral infections.
Collapse
|
8
|
Lueangsakulthai J, Jangpromma N, Temsiripong T, McKendrick J, Khunkitti W, Maddocks S, Klaynongsruang S. A novel antibacterial peptide derived fromCrocodylus siamensishaemoglobin hydrolysate induces membrane permeabilization causing iron dysregulation, oxidative stress and bacterial death. J Appl Microbiol 2017; 123:819-831. [DOI: 10.1111/jam.13539] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/25/2017] [Revised: 07/03/2017] [Accepted: 07/06/2017] [Indexed: 12/22/2022]
Affiliation(s)
- J. Lueangsakulthai
- Protein and Proteomics Research Center for Commercial and Industrial Purposes (ProCCI); Faculty of Science; Khon Kaen University; Khon Kaen Thailand
- Department of Biochemistry; Faculty of Science; Khon Kaen University; Khon Kaen Thailand
| | - N. Jangpromma
- Protein and Proteomics Research Center for Commercial and Industrial Purposes (ProCCI); Faculty of Science; Khon Kaen University; Khon Kaen Thailand
- Office of the Dean; Faculty of Science; Khon Kaen University; Khon Kaen Thailand
| | | | - J.E. McKendrick
- Department of Chemistry; The University of Reading; Reading UK
| | - W. Khunkitti
- Department of Pharmaceutical Technology; Faculty of Pharmaceutical Science; Khon Kaen University; Khon Kaen Thailand
| | - S.E. Maddocks
- Department of Biomedical Sciences; Cardiff School of Health Science; Cardiff Metropolitan University; Cardiff UK
| | - S. Klaynongsruang
- Protein and Proteomics Research Center for Commercial and Industrial Purposes (ProCCI); Faculty of Science; Khon Kaen University; Khon Kaen Thailand
- Department of Biochemistry; Faculty of Science; Khon Kaen University; Khon Kaen Thailand
| |
Collapse
|